,i  #aafth ,,congress  #ast ,session    
,h4 ,r4 #aiee  ,,in ,,the ,,house ,,of  
,,representatives  ,march #bh1 #bjai    
,ms4 ,kuster of ,new ,hampshire 7for    
herself1 ,mr4 ,smith of ,new ,jersey1   
and ,ms4 ,waters7 introduced the        
following bill2 which was referred to   
the ,committee on ,ways and ,means1 and 
in addition to the ,committee on ,energy
 and ,commerce1 for a period to be      
subsequently determined by the ,speaker1
 in each case for consideration of such 
provisions as fall within the           
jurisdiction of the committee concerned 
,a ,,bill  ,to require the              
,administrator of the ,centers for      
,medicare  ,medicaid ,services to       
conduct a study on antipsychotic        
prescribing practices in nonnursing home
 settings under the ,medicare program1  
and for other purposes4  #a4 ,short     
title ,this ,act may be cited as the    
,understanding ,appropriate ,alzheimer's
 ,care ,act of #bjai4  #b4 ,requirement 
of ,administrator of ,centers for       

,medicare  ,medicaid ,services to       
conduct study on antipsychotic          
prescribing practices in nonnursing home
 settings under ,medicare program ,not  
later than the date that is #ah months  
after the date of the enactment of this 
,act1 the ,administrator of the ,centers
 for ,medicare  ,medicaid ,services     
shall1 in coordination with the heads of
 other entities within the ,department  
of ,health and ,human ,services 7as     
determined appropriate by the ,secretary
 of ,health and ,human ,services7 and   
the ,comptroller ,general of the ,united
 ,states--  7#a7 conduct a study on     
antipsychotic prescribing practices in  
nonnursing home settings under the      
,medicare program under title ,,xviii of
 the ,social ,security ,act 7#db        
,u4,s4,c4 #acie et seq47 that assesses--
 7,a7 whether antipsychotic prescribing 
practices in such nonnursing home       
settings are appropriate or             
inappropriate2  7,b7 whether individuals
 who have been prescribed antipsychotic 

medications in such nonnursing home     
settings have had improved health       
outcomes1 taking into account the       
duration of any such prescription2  7,c7
 whether physicians--  7i7 are aware of 
the health risks of antipsychotic       
medications for individuals with        
,alzheimer's disease2 and  7ii7 attempt 
to use nonpharmacological interventions 
before prescribing such medications for 
such individuals2 and  7,d7 whether     
individuals who have been prescribed    
antipsychotic medications in such       
nonnursing home settings1 and the       
families of such individuals1 are aware 
of the health risks of such medications2
 and  7#b7 submit to ,congress and the  
,secretary of ,health and ,human        
,services1 and make publicly available1 
a report on the findings of such study1 
including recommendations for how       
inappropriate antipsychotic prescribing 
practices in such nonnursing home       
settings may be reduced4